FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Apr 21, 2017
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on April 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a706e6f7-46f9-453a-83b5-9047c8f71cf3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1011631
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Merck Sharp & Dohme LLC
18| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Baltimore District Office | |
| January 22, 2025 | Not classified | Baltimore District Office | |
| April 26, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 4, 2020 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1296670 - 2025-11-21
- FDA Inspection 1258902 - 2025-01-22
- FDA Inspection 1210555 - 2023-04-26
- FDA Inspection 1123248 - 2020-03-04
- FDA Inspection 1094564 - 2019-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.